The PRECISE RCT: Evolution of an Early Septic Shock Fluid Resuscitation Trial

Transfusion Medicine Reviews

Volumn 26, Issue 4, 2012, Pages 333-341

  McIntyre, Lauralyn ^{a,b,c,d,e,f,g,h,i,j,k,l}   Fergusson, Dean A ^{a,b,c,d,e,f,g,h,i,j,k,l}   Rowe, Brian ^{a,b,c,d,e,f,g,h,i,j,k,l}   Cook, Deborah J ^{a,b,c,d,e,f,g,h,i,j,k,l}   Arabi, Yaseen ^{a,b,c,d,e,f,g,h,i,j,k,l}   Bagshaw, Sean M ^{a,b,c,d,e,f,g,h,i,j,k,l}   Emond, Marcel ^{a,b,c,d,e,f,g,h,i,j,k,l}   Finfer, Simon ^{a,b,c,d,e,f,g,h,i,j,k,l}   Fox Robichaud, Alison ^{a,b,c,d,e,f,g,h,i,j,k,l}   Gray, Alasdair ^{a,b,c,d,e,f,g,h,i,j,k,l}   Green, Robert ^{a,b,c,d,e,f,g,h,i,j,k,l}   Hebert, Paul ^{a,b,c,d,e,f,g,h,i,j,k,l}   Lang, Eddy ^{a,b,c,d,e,f,g,h,i,j,k,l}   Marshall, John ^{a,b,c,d,e,f,g,h,i,j,k,l}   Stiell, Ian ^{a,b,c,d,e,f,g,h,i,j,k,l}   Tinmouth, Alan ^{a,b,c,d,e,f,g,h,i,j,k,l}   Pagliarello, Joe ^{a,b,c,d,e,f,g,h,i,j,k,l}   Turgeon, Alexis ^{a,b,c,d,e,f,g,h,i,j,k,l}   Walsh, Timothy ^{a,b,c,d,e,f,g,h,i,j,k,l}   Worster, Andrew ^{a,b,c,d,e,f,g,h,i,j,k,l}   Zarychanski, Ryan ^{a,b,c,d,e,f,g,h,i,j,k,l}   more..

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^e LAVAL UNIVERSITY   (Canada)

^f GEORGE INSTITUTE FOR INTERNATIONAL HEALTH   (Australia)

^g ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^h DALHOUSIE UNIVERSITY   (Canada)

ⁱ UNIVERSITY OF CALGARY   (Canada)

^j UNIVERSITY OF TORONTO   (Canada)

^k UNIVERSITY OF OTTAWA   (Canada)

^l UNIVERSITY OF MANITOBA   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIBIOTIC AGENT; CORTICOSTEROID; HETASTARCH;

ACUTE KIDNEY FAILURE; ARTICLE; CONTROLLED STUDY; DEATH; DOUBLE BLIND PROCEDURE; FLUID RESUSCITATION; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; NURSE; PHYSICIAN; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; SEPSIS; SEPTIC SHOCK;

ADULT; AGED; ALBUMINS; FEMALE; FLUID THERAPY; HETASTARCH; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; RENAL REPLACEMENT THERAPY; RESEARCH DESIGN; RESUSCITATION; SALTS; SHOCK, SEPTIC; TREATMENT OUTCOME;

EID: 84866455425     PISSN: 08877963     EISSN: 15329496     Source Type: Journal    
DOI: 10.1016/j.tmrv.2011.11.003     Document Type: Article

References (27)

1. Levy M.M., Dellinger R.P., Townsend S.R., et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med 2010, 36(2):222-231.
2. Rivers E., Nguyen B., Havstad M.A., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345(19):1368-1377.
3. Kumar A., Roberts D., Wood K.E., et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006, 34(6):1589-1596.
4. Kern J.W., Shoemaker W.C. Meta-analysis of hemodynamic optimization in high-risk patients. Crit Care Med 2002, 30(8):1686-1692.
5. Jones A.E., Brown M.D., Trzeciak S., et al. The effect of a quantitative resuscitation strategy on mortality in patients with sepsis: a meta-analysis. Crit Care Med 2008, 36(10):2734-2739.
6. Dellinger R.P., Levy M.M., Carlet J.M., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36(1):296-327.
7. Marik P.E., Varon J. Sepsis: state of the art. Disease-A-Month 2001, 47(10):465-532.
8. McIntyre L.A., Hebert P.C., Fergusson D., Cook D.J., Aziz A. A survey of Canadian intensivists' resuscitation practices in early septic shock. Crit Care 2007, 11(4):R74.
9. Brunkhorst F.M., Engel C., Bloos F., et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008, 358(2):125-139.
10. Schortgen F., Lacherade J.C., Bruneel F., et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 2001, 357(9260):911-916.
11. Wiedermann C.J. Systematic review of randomized clinical trials on the use of hydroxyethyl starch for fluid management in sepsis. BMC Emerg Med 2008, 8:1.
12. Zarychanski R., Turgeon A., Fergusson D., et al. Renal outcomes and mortality following hydroxyethyl starch resuscitation in critically ill patients: a systematic review and meta-analysis of randomized trials. Open Med 2009, 3(4):E196-E209.
13. Dart A.B., Mutter T.C., Ruth C.A., Taback S.P. Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst Rev 2010, (1):CD007594.
14. Finfer S., Bellomo R., Boyce N., French J., Myburgh J., Norton R. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004, 350(22):2247-2256.
15. Finfer S., McEvoy S., Bellomo R., McArthur C., Myburgh J., Norton R. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Med 2011, 37(1):86-96.
16. McIntyre L.A., Fergusson D., Cook D.J., et al. Resuscitating patients with early severe sepsis: a Canadian multicentre observational study. Can J Anesth 2007, 54(10):790-798.
17. McIntyre L., Fergusson D.A., Cook D.J., et al. Fluid Resuscitation with 5% Albumin versus Normal Saline in Early Septic Shock (PRECISE): A Pilot Randomized Controlled Trial. J Crit Care 2011, In Press.
18. McIntyre L.A., Fergusson D., Cook D.J., et al. Fluid resuscitation in the management of early septic shock (FINESS): a randomized controlled feasibility trial. Can J Anesth 2008, 55(12):819-826.
19. Bone R.C., Balk R.A., Cerra F.B., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101(6):1644-1655.
20. Canadian Institute for Health Research NSaERCoCaSSSaHRCoC Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans 2010, http://www.pre.ethics.gc.ca/eng/policy-politique/initiatives/tcps2-eptc2/Default/.
21. Cook D.J., Blythe D., Rischbieth A., et al. Enrollment of intensive care unit patients into clinical studies: a trinational survey of researchers' experiences, beliefs, and practices. Crit Care Med 2008, 36(7):2100-2105.
22. Kho M.E., Duffett M., Willison D.J., Cook D.J., Brouwers M.C. Written informed consent and selection bias in observational studies using medical records: systematic review. Br Med J 2009, b866:338.
23. Burns K.E., Zubrinich C., Marshall J., Cook D. The 'Consent to Research' paradigm in critical care: challenges and potential solutions. Intensive Care Med 2009, 35(10):1655-1658.
24. Angus D.C., Carlet J. Surviving intensive care: a report from the 2002 Brussels Roundtable. Intensive Care Med 2003, 29(3):368-377.
25. Taori G., Ho K.M., George C., et al. Landmark survival as an end-point for trials in critically ill patients-comparison of alternative durations of follow-up: an exploratory analysis. Crit Care 2009, 13(4):R128.
26. Cohen J., Guyatt G., Bernard G., et al. New strategies for clinical trials in patients with sepsis and septic shock. Crit Care Med 2001, 29(4):880-886.
27. Marshall J.C., Cook D.J., Christou N.V., Bernard G.R., Sprung C.L., Sibbald W.J. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 1995, 23(10):1638-1652. [see comments.].